Stock 300016 BEIJING BEILU PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Beilu Pharmaceutical Co., Ltd

Equities

300016

CNE000001QK9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
4.59 CNY +2.23% Intraday chart for Beijing Beilu Pharmaceutical Co., Ltd -10.87% -35.53%
Apr. 21 Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 29 Beijing Beilu Pharmaceutical Co., Ltd Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. for CNY 248 million. CI

Business Summary

Beijing Beilu Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and distribution of contract medium products, anti-diabetic products and anti-anxiety products. The Company’s main products include gadopentetate dimeglumine injection, iohexol injection, Iodoparol injection, Iodixanol injection, ferric ammonium citrate effervescent granules, repaglinide tablets, glimepiride tablets, Jiuwei Zhenxin granules, among others. The Company mainly distributes its products in domestic market.

Number of employees: 952

Sales per Business

CNY in Million2022Weight2023Weight Delta
Contrast Agent
60.1 %
512 66.8 % 535 60.1 % +4.59%
Jiuwei Zhenxin Granules
15.8 %
124 16.3 % 141 15.8 % +13.10%
Raw Materials and Others
13.5 %
70 9.2 % 120 13.5 % +71.17%
Hypoglycemic Agents
10.6 %
59 7.8 % 95 10.6 % +59.02%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
86.4 %
703 91.8 % 769 86.4 % +9.40%
Overseas and Other
13.6 %
63 8.2 % 121 13.6 % +93.74%

Managers

Managers TitleAgeSince
Xu Wang CEO
 Chief Executive Officer 40 10-12-31
Ni Zeng DFI
 Director of Finance/CFO 32 18-05-31
Ze Hui Shao BRD
 Director/Board Member 44 18-09-20
Li Zong BRD
 Director/Board Member 53 00-11-30
Gen Chang Zheng BRD
 Director/Board Member 55 -
Zhi Fang Sun IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Qing Xiang BRD
 Director/Board Member 53 07-04-24
Wei Jiang BRD
 Director/Board Member 51 22-04-19
Gen Chang Zheng BRD
 Director/Board Member 55 -
Li Zong BRD
 Director/Board Member 53 00-11-30
Xu Wang CEO
 Chief Executive Officer 40 10-12-31
Ying Dian Wang BRD
 Director/Board Member 63 19-03-20
Ying Yang CHM
 Chairman 46 15-03-01
Ze Hui Shao BRD
 Director/Board Member 44 18-09-20
Ni Zeng DFI
 Director of Finance/CFO 32 18-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 491,935,061 328,080,760 ( 66.69 %) 0 66.69 %

Shareholders

NameEquities%Valuation
Huashang Fund Management Co., Ltd.
0.5517 %
2,205,000 0.5517 % 2 M ¥
First-Trust Fund Management Co., Ltd.
0.2980 %
1,190,900 0.2980 % 812 408 ¥
China Merchants Fund Management Co., Ltd.
0.2518 %
1,006,550 0.2518 % 686 648 ¥
Gfund Management Co., Ltd.
0.1296 %
518,000 0.1296 % 353 369 ¥
Wanjia Asset Management Co., Ltd.
0.1127 %
450,500 0.1127 % 307 322 ¥
Guolian Fund Management Co. Ltd.
0.0600 %
239,700 0.0600 % 163 519 ¥
Zhong Ou Asset Management Co., Ltd
0.0446 %
178,300 0.0446 % 121 633 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.0295 %
118,100 0.0295 % 80 565 ¥
SWS MU Fund Management Co., Ltd.
0.0183 %
73,100 0.0183 % 49 867 ¥
Hongde Fund Management Co., Ltd.
0.007481 %
29,900 0.007481 % 20 397 ¥

Company contact information

Beijing Beilu Pharmaceutical Co., Ltd.

7/F, Block A, Fenglan Intl Office 32 Xizhimen North Street

100082, Beijing

+

http://www.beilu.com.cn
address Beijing Beilu Pharmaceutical Co., Ltd(300016)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
BEIJING BEILU PHARMACEUTICAL CO., LTD Stock Beijing Beilu Pharmaceutical Co., Ltd
-35.53% 312M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 765B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 248B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 219B
NOVARTIS AG Stock Novartis AG
+11.88% 216B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.73% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300016 Stock
  4. Company Beijing Beilu Pharmaceutical Co., Ltd